Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis

Carcinogenesis

Volumn 24, Issue 2, 2003, Pages 307-315

  Dong, Mei ^a   Guda, Kishore ^a   Nambiar, Prashant R ^a   Rezaie, Anahita ^a   Belinsky, Glenn S ^a   Lambeau, Gérard ^b   Giardina, Charles ^c   Rosenberg, Daniel W ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; AZOXYMETHANE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; MESSENGER RNA; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PROSTAGLANDIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER STAGING; CELL CULTURE; CELL PROTECTION; CELL TYPE; COLON CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; ENZYME SPECIFICITY; GENE EXPRESSION; IN VITRO STUDY; INTESTINE CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; BASE SEQUENCE; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; DINOPROSTONE; DNA PRIMERS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MICE; PHOSPHOLIPASES A; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0037330702     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/24.2.307     Document Type: Article

References (41)

1. Prescott,S.M. and Fitzpatrick,F.A. (2000) Cyclooxygenase-2 and carcinogenesis. Biochim. Biophys. Acta, 1470, M69-78.
2. Lee,S.H., Soyoola,E., Chanmugam,P., Hart,S., Sun,W., Zhong,H., Liou,S., Simmons,D. and Hwang,D. (1992) Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem., 267, 25934-25938.
3. Maier J.A., Hla,T. and Maciag,T. (1990) Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J. Biol. Chem., 265, 10805-10808.
4. Sheng,H., Shao,J. and Dubois,R.N. (2001) K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1. Cancer Res., 61, 2670-2675.
5. Chan,T.A., Morin,P.J., Vogelstein,B. and Kinzler,K.W. (1998) Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc. Natl Acad. Sci. USA, 95, 681-686.
6. Cao,Y., Pearman,A.T., Zimmerman,G.A., McIntyre,T.M. and Prescott,S.M. (2000) Intracellular unesterified arachidonic acid signals apoptosis. Proc. Natl Acad. Sci. USA, 97, 11280-11285.
7. Wissing,D., Mouritzen,H., Egeblad,M., Poirier,G.G. and Jaattela,M. (1997) Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis. Proc. Natl Acad. Sci. USA, 94, 5073-5077.
8. Duan,L., Gan,H., Arm,J. and Remold,H.G. (2001) Cytosolic phospholipase A2 participates with TNF-alpha in the induction of apoptosis of human macrophages infected with Mycobacterium tuberculosis H37Ra. J. Immunol., 166, 7469-7476.
9. O'Brien,J.B., Piddington,D.L., Voelkel-Johnson,C., Richards,D.J., Hadley,L.A. and Laster,S.M. (1998) Sustained phosphorylation of cytosolic phospholipase A2 accompanies cycloheximide- and adenovirus-induced susceptibility to TNF. J. Immunol., 161, 1525-1532.
10. Murakami,M., Kambe,T., Shimbara,S., Higashino,K., Hanasaki,K., Arita,H., Horiguchi,M., Arita,M., Arai,H., Inoue,K. and Kudo,I. (1999) Different functional aspects of the group II subfamily (Types IIA and V) and type X secretory phospholipase A (2)s in regulating arachidonic acid release and prostaglandin generation. Implications of cyclooxygenase-2 induction and phospholipid scramblase-mediated cellular membrane perturbation. J. Biol. Chem., 274, 31435-31444.
11. Leslie,C.C. (1997) Properties and regulation of cytosolic phospholipase A2. J. Biol. Chem., 272, 16709-16712.
12. Bonventre,J.V., Huang,Z., Taheri,M.R., O'Leary,E., Li,E., Moskowitz,M.A. and Sapirstein,A. (1997) Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature, 390, 622-625.
13. Hong,K.H., Bonventre,J.C., O'Leary,E., Bonventre,J.V. and Lander,E.S. (2001) Deletion of cytosolic phospholipase A (2) suppresses Apc (Min)-induced tumorigenesis. Proc. Natl Acad. Sci. USA, 98, 3935-3939.
14. Takaku,K., Sonoshita,M., Sasaki,N., Uozumi,N., Doi,Y, Shimizu,T. and Taketo,M.M. (2000) Suppression of intestinal polyposis in Apc (delta 716) knockout mice by an additional mutation in the cytosolic phospholipase A (2) gene. J. Biol. Chem., 275, 34013-34016.
15. Cupillard,L., Mulherkar,R., Gomez,N., Kadam,S., Valentin,E., Lazdunski,M. and Lambeau,G. (1999) Both group IB and group IIA secreted phospholipases A2 are natural ligands of the mouse 180-kDa M-type receptor. J. Biol. Chem., 274, 7043-7051.
16. Cormier,R.T., Hong,K.H., Halberg,R.B., Hawkins,T.L., Richardson,P., Mulherkar,R., Dove,W.F. and Lander,E.S. (1997) Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nature Genet., 17, 88-91.
17. Reddy,S.T., Winstead,M.V, Tischfield,J.A. and Herschman,H.R. Analysis of the secretory phospholipase A2 that mediates prostaglandin production in mast cells. (1997) J. Biol. Chem., 272, 13591-13596.
18. Murakami,M., Shimbara,S., Kambe,T., Kuwata,H., Winstead,M.V., Tischfield,J.A. and Kudo,I. (1998) The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2. J. Biol. Chem., 273, 14411-14423.
19. Papanikolaou,A., Wang,Q.S., Delker,D.A. and Rosenberg,D.W. (1998) Azoxymethane-induced colon tumors and aberrant crypt foci in mice of different genetic susceptibility. Cancer Lett., 130, 29-34.
20. Maltzman,T., Whittington,J., Driggers,L., Stephens,J. and Ahnen,D. (1997) AOM-induced mouse colon tumors do not express full-length APC protein. Carcinogenesis, 18, 2435-2439.
21. Wang,Q.S., Papanikolaou,A., Sabourin,C.L. and Rosenberg,D.W. (1998) Altered expression of cyclin D1 and cyclin-dependent kinase 4 in azoxymethane-induced mouse colon tumorigenesis. Carcinogenesis, 19, 2001-2006.
22. Bolt,A.B., Papanikolaou,A., Delker,D.A., Wang,Q.S. and Rosenberg,D.W. (2000) Azoxymethane induces Ki-ras activation in the tumor resistant AKR/J mouse colon. Mol. Carcinogen., 27, 210-218.
23. Guda,K., Giardina,C., Nambiar,P., Cui,H.Y. and Rosenberg,D.W. (2001) Aberrant transforming growth factor-beta signaling in azoxymethane-induced mouse colon tumors. Mol. Carcinogen., 31, 204-213.
24. Nambiar,P., Giardina,C., Guda,K., Aizu,W., Raja,R. and Rosenberg,D.W. (2002) Role of the ARF-p53 pathway in an in vivo murine colon tumor model. Cancer Res., 62, 3667-3674.
25. Bhat,M.K., Mueller-Harvey,I., Sumner,I.G. and Goodenough,P.W. (1993) Simplified methods for the synthesis of 2-hexadecanoylthio-1-ethylphosphorylcholine and for the determination of phospholipase A2 activity. Biochim. Biophys. Acta, 1166, 244-250.
26. Whitehead,R.H., VanEeden,P.E., Noble,M.D., Ataliotis,P. and Jat,P.S. (1993) Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice. Proc. Natl Acad. Sci. USA, 90, 587-591.
27. Oshima,M., Dinchuk,J.E., Kargman,S.L., Oshima,H., Hancock,B., Kwong,E., Trzaskos,J.M., Evans,J.F. and Taketo,M.M. (1996) Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803-809.
28. Pai,R., Soreghan,B., Szabo,I.L., Pavelka,M., Baatar,D. and Tarnawski,A.S. (2002) Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nature Med., 8, 289-293.
29. Hansen-Petrik,M.B., McEntee,M.F., Jull,B., Shi,H., Zemel,M.B. and Whelan,J. (2002) Prostaglandin E (2) protects intestinal tumors from nonsteroidal anti-inflammatory drug-induced regression in Apc (Min/+) mice. Cancer Res., 62, 403-408.
30. Papanikolaou,A., Wang,Q.S., Mulherkar,R., Bolt,A. and Rosenberg,D.W. (2000) Expression analysis of the group IIA secretory phospholipase A (2) in mice with differential susceptibility to azoxymethane-induced colon tumorigenesis. Carcinogenesis, 21, 133-138.
31. Morioka,Y., Saiga,A., Yokota,Y. et al. (2000) Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor. Arch. Biochem. Biophys., 381, 31-42.
32. Lambeau,G. and Lazdunski,M. (1999) Receptors for a growing family of. secreted phospholipases A2. Trends Pharmacol. Sci., 20, 162-170.
33. Schievella,A.R., Regier,M.K. Smith,W.L. and Lin,L.L. (1995) Calcium-mediated translocation of cytosolic phospholipase A2 to the nuclear envelope and endoplasmic reticulum. J. Biol. Chem., 270, 30749-30754.
34. Chung,D.C. (2000) The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology, 119, 854-865.
35. Giardiello,F.M., Hamilton,S.R., Krush,A.J., Piantadosi,S., Hylind,L.M., Celano,P., Booker,S.V., Robinson,C.R. and Offerhaus,G.J. (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328, 1313-1316.
36. Fukutake,M., Nakatsugi,S., Isoi,T. et al. (1998) Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice. Carcinogenesis, 19, 1939-1942.
37. Reddy,B.S., Hirose,Y., Lubet,R., Steele,V., Kelloff,G., Paulson,S., Seibert,K. and Rao,C.V. (2002) Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res., 62, 165-170.
38. Mutoh,M., Watanabe,K., Kitamura,T. et al. (2002) Involvement of prostaglandin E receptor subtype EP (4) in colon carcinogenesis. Cancer Res., 62, 28-32.
39. Li,H., Schut,H.A., Conran,P., Kramer,P.M., Lubet,R.A., Steele,V.E., Hawk,E.E., Kelloff,G.J. and Pereira,M.A. (1999) Prevention by aspirin and its combination with alpha-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon. Carcinogenesis, 20, 425-430.
40. Soydan,A.S., Tavares,I.A., Weech,P.K., Temblay,N.M. and Bennett,A. (1996) High molecular weight phospholipase A2 and fatty acids in human colon tumours and associated normal tissue. Eur. J. Cancer, 32, 1781-1787.
41. Dimberg,J., Samuelsson,A., Hugander,A. and Soderkvist,P. (1998) Gene expression of cyclooxygenase-2, group II and cytosolic phospholipase A2 in human colorectal cancer. Anticancer Res., 18, 3283-3287.